6
2A,C). Notably, this phenotype that was not exacerbated by elimination of maternal 1 4 5 Tead4 (Fig. S2A and Fig. 2A,C) , consistent with the absence of detectable Tead4 in led to precocious SOX2 at the 8-cell stage (Fig. 2B,D) . The presence of wild-type, 1 4 8 paternal alleles of Wwtr1 and/or Yap1 did not rescue SOX2 in the maternally null 1 4 9 embryos (Fig. 2B, D) . Therefore, maternally provided WWTR1/YAP1 and zygotically 1 5 0 expressed TEAD4 repress Sox2 expression at the 8-cell stage. We next evaluated SOX2 in embryos lacking maternal Wwtr1;Yap1 at the 4-cell stage. We observed that 4-cell embryos lacking maternal Wwtr1 and Yap1 occasionally 1 5 4 exhibited weak ectopic SOX2 (Fig. S2D,E ). However, SOX2 was never detected in 4-1 5 5 cell embryos lacking Tead4 (Fig. S2C ). These observations suggest that Wwtr1 and 1 5 6
Yap1 partner with other factors to regulate the onset of Sox2 expression at the 4-cell 1 5 7 stage and point to a requirement for other TEAD proteins that are expressed at the 4- for Sox2 expression beyond regulated TEAD4/WWTR1/YAP1 activity. Rather, our 1 6 8 results suggest that the mechanism regulating the onset of Sox2 expression is that 1 6 9 constitutive repression of Sox2 by TEAD4/WWTR1/YAP1 is relieved once cells are 1 7 0 positioned inside the embryo at the 16-cell stage. In many contexts, TEAD4/WWTR1/YAP1 activity is repressed by the HIPPO pathway regulating initial Sox2 expression, we therefore examined whether Sox2 expression is 1 7 7 LATS1/2-sensitive prior to the 16-cell stage. We injected mRNA encoding Lats2 into both blastomeres of 2-cell stage embryos,
which is sufficient to inactivate the TEAD4/WWTR1/YAP1 complex during blastocyst We observed in published RNA-seq data sets that Lats1 and Lats2 are expressed in 4- interesting future direction of discovering how TEAD4/WWTR1/YAP1 escape inhibition 1 9 3 by LATS kinases prior to the 16-cell stage, which is not currently understood. TEAD4/WWTR1/YAP1 may repress Sox2 expression through a direct mechanism 1 9 6
While the TEAD4/WWTR1/YAP1 complex is widely recognized as a transcriptional 1 9 7
activator, it has more recently been shown to act as a transcriptional repressor (Beyer et To test these models, we employed variants of Tead4 in which the WWTR1/YAP1 2 0 4 interaction domain has been replaced with either the transcriptional activator VP16 the 8-cell stage with co-injection of GFP (Fig. 4B ). We observed that overexpression of 2 1 4
Tead4VP16, but not Tead4EnR induced SOX2 (Fig. 4C,D) . These observations are 2 1 5 consistent with the direct repression of Sox2 by TEAD4/WWTR1/YAP1. This study highlights distinct phases of Sox2 regulation occurring during the and OCT4 work together ensure that Sox2 expression is maintained ( Fig 4E, box 3) . Finally, as the embryo approaches implantation, Nanog and Oct4 become individually 2 2 6 required to sustain Sox2 expression ( Fig. 4E , box 4). University. Wild type embryos were generated by mating CD-1 mice (Charles River).
8 1
Female mice used in this study were between six weeks and six months of age and Embryos were fixed in 4% formaldehyde (Polysciences) for 10 minutes, permeabilized 3 1 1 with 0.5% Triton X-100 (Millipore-Sigma) for 30 minutes and blocked with 10% FBS, 3 1 2 0.1% Triton X-100 for at least 1 hour at room temperature or longer at 4ºC. Primary staining was defined as the level observed in non-mutant embryos, which was uniform among inside cells. In Fig. 1, S1 , 2, and S2, embryo genotypes were not known prior to analysis. In Fig. 3 and 4 embryos were grouped according to injection performed, and therefore the researcher was not blind to embryo treatment.
Embryo Genotyping
For embryos at the 8-cell stage or older, DNA was extracted from fixed embryos after imaging using the Extract-N-Amp kit (Millipore-Sigma) in a total volume of 10 µl. For embryos at the 4-cell stage, DNA was extracted from fixed embryos in a total volume of 5 µl. 1 µl of extracted DNA was used as template, with allele specific primers (Table   S1 ). 8 2 trophectoderm lineage at the beginning of mammalian development. Development 
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